US 12,129,221 B2
Difluoro phenyl amide RIP1 inhibitor
Zhiyuan Zhang, Beijing (CN); Yaning Su, Beijing (CN); Yi Yang, Beijing (CN); Guozheng Wang, Beijing (CN); Wendong Liu, Beijing (CN); Yongfen Ma, Beijing (CN); and Yan Ren, Beijing (CN)
Assigned to SIRONAX LTD, Grand Cayman (KY)
Filed by SIRONAX LTD, Grand Cayman (KY)
Filed on May 19, 2021, as Appl. No. 17/325,193.
Application 17/325,193 is a continuation of application No. PCT/CN2019/119676, filed on Nov. 20, 2019.
Claims priority of application No. PCT/CN2018/116555 (WO), filed on Nov. 20, 2018.
Prior Publication US 2021/0284598 A1, Sep. 16, 2021
Int. Cl.
C07C 233/13
(2006.01);
A61P 25/28
(2006.01);
A61P 31/12
(2006.01);
A61P 35/00
(2006.01)
CPC
C07C 233/13
(2013.01) [
A61P 25/28
(2018.01);
A61P 31/12
(2018.01);
A61P 35/00
(2018.01)]
4 Claims
1. An amide compound of structure:
or a pharmaceutically acceptable salt, hydrate, or stereoisomer thereof.